RSS   Newsletter   Contact   Advertise with us
Post Online Media

Avanir appoints Richard Malamut as SVP

Richard MalamutAvanir Pharmaceuticals, Inc., a biopharmaceutical company, announced that Richard Malamut has joined the company as SVP, research and development, and chief medical officer.
Article continues below

READ MORE Avanir Pharmaceuticals: Michael McFadden new vice president

Dr. Malamut brings more than 17 years of academic and clinical expertise in neurology.

Prior to Avanir, he was the senior vice president of global clinical development at Teva Pharmaceutical Industries Ltd., where he was responsible for directing all aspects within clinical development for the company’s pain, oncology and neuropsychiatry products.

Prior to that, he had roles of increasing responsibility working in Pain, Psychiatry, and Neurodegenerative disease at Bristol-Myers Squibb and AstraZeneca, as well as consulting for Avanir, Schwarz Bioscience and Shire Pharmaceuticals.

Dr. Malamut earned his medical degree from Hahnemann University in Philadelphia and has completed both a neurology residency at Pennsylvania Hospital in Philadelphia and EMG/Neuromuscular Disease fellowship at LSU in New Orleans.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy